nodes	percent_of_prediction	percent_of_DWPC	metapath
Erlotinib—NR1I2—metabolic syndrome X	0.663	0.852	CbGaD
Erlotinib—ALB—metabolic syndrome X	0.115	0.147	CbGaD
Erlotinib—Vandetanib—FMO3—metabolic syndrome X	0.00501	0.85	CrCbGaD
Erlotinib—Nail disorder—Metformin—metabolic syndrome X	0.00204	0.072	CcSEcCtD
Erlotinib—JAK3—adipose tissue—metabolic syndrome X	0.00203	0.0422	CbGeAlD
Erlotinib—FLT3—cardiovascular system—metabolic syndrome X	0.00182	0.0377	CbGeAlD
Erlotinib—NR1I2—liver—metabolic syndrome X	0.00178	0.037	CbGeAlD
Erlotinib—Rigors—Metformin—metabolic syndrome X	0.00162	0.0572	CcSEcCtD
Erlotinib—ABL2—adipose tissue—metabolic syndrome X	0.00153	0.0318	CbGeAlD
Erlotinib—EGFR—adipose tissue—metabolic syndrome X	0.0015	0.031	CbGeAlD
Erlotinib—MKNK1—cardiovascular system—metabolic syndrome X	0.00148	0.0306	CbGeAlD
Erlotinib—PIP4K2C—adipose tissue—metabolic syndrome X	0.00145	0.0301	CbGeAlD
Erlotinib—ULK3—adipose tissue—metabolic syndrome X	0.00138	0.0287	CbGeAlD
Erlotinib—TNK1—liver—metabolic syndrome X	0.00131	0.0272	CbGeAlD
Erlotinib—MKNK1—adipose tissue—metabolic syndrome X	0.0013	0.027	CbGeAlD
Erlotinib—Neuropathy—Metformin—metabolic syndrome X	0.00124	0.0438	CcSEcCtD
Erlotinib—SLK—adipose tissue—metabolic syndrome X	0.00123	0.0256	CbGeAlD
Erlotinib—STK10—cardiovascular system—metabolic syndrome X	0.00122	0.0252	CbGeAlD
Erlotinib—STK10—kidney—metabolic syndrome X	0.00119	0.0247	CbGeAlD
Erlotinib—FLT3—liver—metabolic syndrome X	0.00113	0.0233	CbGeAlD
Erlotinib—UGT1A1—kidney—metabolic syndrome X	0.00112	0.0233	CbGeAlD
Erlotinib—MAP2K5—cardiovascular system—metabolic syndrome X	0.00109	0.0225	CbGeAlD
Erlotinib—ABL2—liver—metabolic syndrome X	0.00107	0.0223	CbGeAlD
Erlotinib—STK10—adipose tissue—metabolic syndrome X	0.00107	0.0223	CbGeAlD
Erlotinib—EGFR—liver—metabolic syndrome X	0.00105	0.0218	CbGeAlD
Erlotinib—PIP4K2C—liver—metabolic syndrome X	0.00102	0.0211	CbGeAlD
Erlotinib—Renal impairment—Metformin—metabolic syndrome X	0.00101	0.0356	CcSEcCtD
Erlotinib—ULK3—liver—metabolic syndrome X	0.000971	0.0201	CbGeAlD
Erlotinib—MAP2K5—adipose tissue—metabolic syndrome X	0.000958	0.0199	CbGeAlD
Erlotinib—MKNK1—liver—metabolic syndrome X	0.000914	0.0189	CbGeAlD
Erlotinib—Dehydration—Metformin—metabolic syndrome X	0.000892	0.0315	CcSEcCtD
Erlotinib—SLK—liver—metabolic syndrome X	0.000865	0.0179	CbGeAlD
Erlotinib—ABL1—cardiovascular system—metabolic syndrome X	0.000838	0.0174	CbGeAlD
Erlotinib—SLCO2B1—kidney—metabolic syndrome X	0.000827	0.0172	CbGeAlD
Erlotinib—ABL1—kidney—metabolic syndrome X	0.00082	0.017	CbGeAlD
Erlotinib—Pancreatitis—Metformin—metabolic syndrome X	0.000813	0.0287	CcSEcCtD
Erlotinib—Neutropenia—Metformin—metabolic syndrome X	0.000775	0.0274	CcSEcCtD
Erlotinib—STK10—liver—metabolic syndrome X	0.000752	0.0156	CbGeAlD
Erlotinib—SLCO2B1—adipose tissue—metabolic syndrome X	0.000746	0.0155	CbGeAlD
Erlotinib—ABL1—adipose tissue—metabolic syndrome X	0.000739	0.0153	CbGeAlD
Erlotinib—Infestation—Metformin—metabolic syndrome X	0.000739	0.0261	CcSEcCtD
Erlotinib—Infestation NOS—Metformin—metabolic syndrome X	0.000739	0.0261	CcSEcCtD
Erlotinib—Neuropathy peripheral—Metformin—metabolic syndrome X	0.000724	0.0256	CcSEcCtD
Erlotinib—UGT1A1—liver—metabolic syndrome X	0.000711	0.0147	CbGeAlD
Erlotinib—CYP1B1—cardiovascular system—metabolic syndrome X	0.00071	0.0147	CbGeAlD
Erlotinib—Hepatobiliary disease—Metformin—metabolic syndrome X	0.000699	0.0247	CcSEcCtD
Erlotinib—CYP1B1—kidney—metabolic syndrome X	0.000695	0.0144	CbGeAlD
Erlotinib—MAP2K5—liver—metabolic syndrome X	0.000672	0.0139	CbGeAlD
Erlotinib—Hepatitis—Metformin—metabolic syndrome X	0.000664	0.0234	CcSEcCtD
Erlotinib—Connective tissue disorder—Metformin—metabolic syndrome X	0.000652	0.023	CcSEcCtD
Erlotinib—CYP1B1—adipose tissue—metabolic syndrome X	0.000626	0.013	CbGeAlD
Erlotinib—Eye disorder—Metformin—metabolic syndrome X	0.00062	0.0219	CcSEcCtD
Erlotinib—Mediastinal disorder—Metformin—metabolic syndrome X	0.000598	0.0211	CcSEcCtD
Erlotinib—Chills—Metformin—metabolic syndrome X	0.000595	0.021	CcSEcCtD
Erlotinib—ABCB1—blood vessel—metabolic syndrome X	0.000584	0.0121	CbGeAlD
Erlotinib—Malnutrition—Metformin—metabolic syndrome X	0.000578	0.0204	CcSEcCtD
Erlotinib—Erythema—Metformin—metabolic syndrome X	0.000578	0.0204	CcSEcCtD
Erlotinib—Flatulence—Metformin—metabolic syndrome X	0.000569	0.0201	CcSEcCtD
Erlotinib—ORM1—liver—metabolic syndrome X	0.000546	0.0113	CbGeAlD
Erlotinib—CYP2C8—kidney—metabolic syndrome X	0.000532	0.011	CbGeAlD
Erlotinib—SLCO2B1—liver—metabolic syndrome X	0.000523	0.0108	CbGeAlD
Erlotinib—ABL1—liver—metabolic syndrome X	0.000518	0.0108	CbGeAlD
Erlotinib—Syncope—Metformin—metabolic syndrome X	0.000518	0.0183	CcSEcCtD
Erlotinib—Loss of consciousness—Metformin—metabolic syndrome X	0.000508	0.0179	CcSEcCtD
Erlotinib—Chest pain—Metformin—metabolic syndrome X	0.000492	0.0174	CcSEcCtD
Erlotinib—Myalgia—Metformin—metabolic syndrome X	0.000492	0.0174	CcSEcCtD
Erlotinib—CYP1A1—kidney—metabolic syndrome X	0.000491	0.0102	CbGeAlD
Erlotinib—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.000488	0.0173	CcSEcCtD
Erlotinib—CYP3A5—kidney—metabolic syndrome X	0.00048	0.00996	CbGeAlD
Erlotinib—ALB—liver—metabolic syndrome X	0.000478	0.00992	CbGeAlD
Erlotinib—Oedema—Metformin—metabolic syndrome X	0.000471	0.0167	CcSEcCtD
Erlotinib—Infection—Metformin—metabolic syndrome X	0.000468	0.0166	CcSEcCtD
Erlotinib—ABCG2—adipose tissue—metabolic syndrome X	0.000466	0.00967	CbGeAlD
Erlotinib—Shock—Metformin—metabolic syndrome X	0.000464	0.0164	CcSEcCtD
Erlotinib—Nervous system disorder—Metformin—metabolic syndrome X	0.000462	0.0163	CcSEcCtD
Erlotinib—Thrombocytopenia—Metformin—metabolic syndrome X	0.000462	0.0163	CcSEcCtD
Erlotinib—Skin disorder—Metformin—metabolic syndrome X	0.000458	0.0162	CcSEcCtD
Erlotinib—Vandetanib—ALB—metabolic syndrome X	0.000455	0.0771	CrCbGaD
Erlotinib—Anorexia—Metformin—metabolic syndrome X	0.000449	0.0159	CcSEcCtD
Erlotinib—CYP1A1—adipose tissue—metabolic syndrome X	0.000443	0.00918	CbGeAlD
Erlotinib—CYP1B1—liver—metabolic syndrome X	0.000439	0.0091	CbGeAlD
Erlotinib—CYP3A5—adipose tissue—metabolic syndrome X	0.000433	0.00897	CbGeAlD
Erlotinib—Gefitinib—ALB—metabolic syndrome X	0.000432	0.0732	CrCbGaD
Erlotinib—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.000429	0.0152	CcSEcCtD
Erlotinib—Dyspnoea—Metformin—metabolic syndrome X	0.00042	0.0149	CcSEcCtD
Erlotinib—Dyspepsia—Metformin—metabolic syndrome X	0.000415	0.0147	CcSEcCtD
Erlotinib—Decreased appetite—Metformin—metabolic syndrome X	0.00041	0.0145	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.000407	0.0144	CcSEcCtD
Erlotinib—Fatigue—Metformin—metabolic syndrome X	0.000406	0.0144	CcSEcCtD
Erlotinib—Constipation—Metformin—metabolic syndrome X	0.000403	0.0142	CcSEcCtD
Erlotinib—Gastrointestinal pain—Metformin—metabolic syndrome X	0.000385	0.0136	CcSEcCtD
Erlotinib—Abdominal pain—Metformin—metabolic syndrome X	0.000373	0.0132	CcSEcCtD
Erlotinib—CYP3A4—kidney—metabolic syndrome X	0.00036	0.00747	CbGeAlD
Erlotinib—CYP2D6—kidney—metabolic syndrome X	0.000355	0.00735	CbGeAlD
Erlotinib—Asthenia—Metformin—metabolic syndrome X	0.000338	0.012	CcSEcCtD
Erlotinib—CYP2C8—liver—metabolic syndrome X	0.000336	0.00697	CbGeAlD
Erlotinib—Pruritus—Metformin—metabolic syndrome X	0.000334	0.0118	CcSEcCtD
Erlotinib—ABCG2—liver—metabolic syndrome X	0.000327	0.00678	CbGeAlD
Erlotinib—Diarrhoea—Metformin—metabolic syndrome X	0.000323	0.0114	CcSEcCtD
Erlotinib—CYP1A2—liver—metabolic syndrome X	0.000315	0.00652	CbGeAlD
Erlotinib—Dizziness—Metformin—metabolic syndrome X	0.000312	0.011	CcSEcCtD
Erlotinib—CYP1A1—liver—metabolic syndrome X	0.00031	0.00644	CbGeAlD
Erlotinib—CYP3A5—liver—metabolic syndrome X	0.000303	0.00629	CbGeAlD
Erlotinib—Vomiting—Metformin—metabolic syndrome X	0.0003	0.0106	CcSEcCtD
Erlotinib—Rash—Metformin—metabolic syndrome X	0.000297	0.0105	CcSEcCtD
Erlotinib—Dermatitis—Metformin—metabolic syndrome X	0.000297	0.0105	CcSEcCtD
Erlotinib—Headache—Metformin—metabolic syndrome X	0.000295	0.0104	CcSEcCtD
Erlotinib—Nausea—Metformin—metabolic syndrome X	0.00028	0.0099	CcSEcCtD
Erlotinib—ABCB1—cardiovascular system—metabolic syndrome X	0.000261	0.00541	CbGeAlD
Erlotinib—ABCB1—kidney—metabolic syndrome X	0.000255	0.00529	CbGeAlD
Erlotinib—ABCB1—adipose tissue—metabolic syndrome X	0.00023	0.00477	CbGeAlD
Erlotinib—CYP3A4—liver—metabolic syndrome X	0.000228	0.00472	CbGeAlD
Erlotinib—CYP2D6—liver—metabolic syndrome X	0.000224	0.00465	CbGeAlD
Erlotinib—ABCB1—liver—metabolic syndrome X	0.000161	0.00334	CbGeAlD
Erlotinib—CYP1A2—Metabolism—APOA5—metabolic syndrome X	9.49e-06	6.79e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—FABP4—metabolic syndrome X	9.48e-06	6.78e-05	CbGpPWpGaD
Erlotinib—ALB—Platelet activation, signaling and aggregation—AKT1—metabolic syndrome X	9.48e-06	6.78e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—TGFB1—metabolic syndrome X	9.45e-06	6.76e-05	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—IL6—metabolic syndrome X	9.45e-06	6.76e-05	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—INS—metabolic syndrome X	9.38e-06	6.71e-05	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—IL6—metabolic syndrome X	9.37e-06	6.7e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—SERPINE1—metabolic syndrome X	9.35e-06	6.69e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—NAMPT—metabolic syndrome X	9.34e-06	6.68e-05	CbGpPWpGaD
Erlotinib—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	9.33e-06	6.67e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—APOE—metabolic syndrome X	9.32e-06	6.66e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—GOT1—metabolic syndrome X	9.29e-06	6.64e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—GGT1—metabolic syndrome X	9.29e-06	6.64e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—LIPC—metabolic syndrome X	9.28e-06	6.64e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—GCK—metabolic syndrome X	9.28e-06	6.64e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—APOC3—metabolic syndrome X	9.23e-06	6.6e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	9.22e-06	6.59e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—APOA1—metabolic syndrome X	9.21e-06	6.59e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—SCARB1—metabolic syndrome X	9.1e-06	6.51e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	9.03e-06	6.46e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—HSD11B1—metabolic syndrome X	8.98e-06	6.43e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—CETP—metabolic syndrome X	8.96e-06	6.4e-05	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—AKT1—metabolic syndrome X	8.93e-06	6.39e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—NOS3—metabolic syndrome X	8.93e-06	6.39e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	8.93e-06	6.39e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—PPARG—metabolic syndrome X	8.92e-06	6.38e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	8.9e-06	6.36e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	8.85e-06	6.33e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—SREBF1—metabolic syndrome X	8.84e-06	6.32e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—TRIB3—metabolic syndrome X	8.82e-06	6.31e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—ABCA1—metabolic syndrome X	8.79e-06	6.29e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—SLC2A4—metabolic syndrome X	8.79e-06	6.29e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—INS—metabolic syndrome X	8.75e-06	6.26e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—ABCA1—metabolic syndrome X	8.74e-06	6.25e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—SLC2A4—metabolic syndrome X	8.74e-06	6.25e-05	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—AKT1—metabolic syndrome X	8.71e-06	6.23e-05	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—AKT1—metabolic syndrome X	8.64e-06	6.18e-05	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—ALB—metabolic syndrome X	8.6e-06	6.15e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—HMGCR—metabolic syndrome X	8.59e-06	6.15e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—GOT2—metabolic syndrome X	8.59e-06	6.15e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—SCARB1—metabolic syndrome X	8.58e-06	6.13e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—AGT—metabolic syndrome X	8.52e-06	6.09e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—GGT1—metabolic syndrome X	8.52e-06	6.09e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—GOT1—metabolic syndrome X	8.52e-06	6.09e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—GGT1—metabolic syndrome X	8.47e-06	6.06e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—GOT1—metabolic syndrome X	8.47e-06	6.06e-05	CbGpPWpGaD
Erlotinib—ABCB1—Transmembrane transport of small molecules—ALB—metabolic syndrome X	8.43e-06	6.03e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—LEP—metabolic syndrome X	8.35e-06	5.97e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—APOE—metabolic syndrome X	8.35e-06	5.97e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—APOB—metabolic syndrome X	8.34e-06	5.97e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—SREBF1—metabolic syndrome X	8.33e-06	5.95e-05	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—IL6—metabolic syndrome X	8.27e-06	5.92e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—APOA1—metabolic syndrome X	8.25e-06	5.9e-05	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—NOS3—metabolic syndrome X	8.23e-06	5.88e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—PTGS2—metabolic syndrome X	8.17e-06	5.84e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—PPARG—metabolic syndrome X	8.12e-06	5.81e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PLA2G4A—metabolic syndrome X	8.12e-06	5.8e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—GOT2—metabolic syndrome X	8.1e-06	5.79e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—HMGCR—metabolic syndrome X	8.1e-06	5.79e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—ALB—metabolic syndrome X	8.02e-06	5.74e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—G6PD—metabolic syndrome X	8.01e-06	5.73e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—LPL—metabolic syndrome X	7.97e-06	5.7e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—INS—metabolic syndrome X	7.96e-06	5.69e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—NAMPT—metabolic syndrome X	7.91e-06	5.66e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—APOB—metabolic syndrome X	7.88e-06	5.64e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	7.87e-06	5.63e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—GCK—metabolic syndrome X	7.86e-06	5.62e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—LIPC—metabolic syndrome X	7.86e-06	5.62e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—HDAC3—metabolic syndrome X	7.82e-06	5.59e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—APOC3—metabolic syndrome X	7.82e-06	5.59e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—TGFB1—metabolic syndrome X	7.71e-06	5.51e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—NOS3—metabolic syndrome X	7.67e-06	5.49e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PLA2G4A—metabolic syndrome X	7.67e-06	5.48e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—ABCA1—metabolic syndrome X	7.66e-06	5.48e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—SLC2A4—metabolic syndrome X	7.66e-06	5.48e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—GCKR—metabolic syndrome X	7.64e-06	5.46e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—LPA—metabolic syndrome X	7.64e-06	5.46e-05	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—AKT1—metabolic syndrome X	7.63e-06	5.46e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CETP—metabolic syndrome X	7.59e-06	5.43e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—CD36—metabolic syndrome X	7.57e-06	5.41e-05	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—PTGS2—metabolic syndrome X	7.53e-06	5.38e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—LPL—metabolic syndrome X	7.53e-06	5.38e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—IRS1—metabolic syndrome X	7.45e-06	5.33e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—GOT1—metabolic syndrome X	7.42e-06	5.31e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—GGT1—metabolic syndrome X	7.42e-06	5.31e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PLA2G6—metabolic syndrome X	7.4e-06	5.29e-05	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—AKT1—metabolic syndrome X	7.33e-06	5.24e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—APOA5—metabolic syndrome X	7.32e-06	5.24e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—ALB—metabolic syndrome X	7.3e-06	5.22e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—SCARB1—metabolic syndrome X	7.27e-06	5.2e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—APOB—metabolic syndrome X	7.23e-06	5.17e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—ABCA1—metabolic syndrome X	7.22e-06	5.16e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—SLC2A4—metabolic syndrome X	7.22e-06	5.16e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—APOB—metabolic syndrome X	7.19e-06	5.14e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—CD36—metabolic syndrome X	7.15e-06	5.11e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—INS—metabolic syndrome X	7.13e-06	5.1e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—IL6—metabolic syndrome X	7.12e-06	5.09e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	7.07e-06	5.06e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—SREBF1—metabolic syndrome X	7.05e-06	5.04e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PPARA—metabolic syndrome X	7.04e-06	5.03e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PLA2G4A—metabolic syndrome X	7.03e-06	5.03e-05	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—TGFB1—metabolic syndrome X	7.03e-06	5.02e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—PTGS2—metabolic syndrome X	7.02e-06	5.02e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CCL2—metabolic syndrome X	7.02e-06	5.02e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—GGT1—metabolic syndrome X	6.99e-06	5e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—GOT1—metabolic syndrome X	6.99e-06	5e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PLA2G4A—metabolic syndrome X	6.99e-06	5e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—NOS3—metabolic syndrome X	6.98e-06	4.99e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—LPL—metabolic syndrome X	6.9e-06	4.93e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—IGF1—metabolic syndrome X	6.9e-06	4.93e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—GOT2—metabolic syndrome X	6.86e-06	4.91e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—HMGCR—metabolic syndrome X	6.86e-06	4.91e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—LPL—metabolic syndrome X	6.86e-06	4.91e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—AGT—metabolic syndrome X	6.82e-06	4.87e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—TRIB3—metabolic syndrome X	6.81e-06	4.87e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—APOE—metabolic syndrome X	6.68e-06	4.78e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PPARA—metabolic syndrome X	6.65e-06	4.75e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—APOA1—metabolic syndrome X	6.6e-06	4.72e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—AKT1—metabolic syndrome X	6.57e-06	4.7e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—CD36—metabolic syndrome X	6.56e-06	4.69e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—SERPINE1—metabolic syndrome X	6.55e-06	4.68e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—CD36—metabolic syndrome X	6.52e-06	4.66e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—AGT—metabolic syndrome X	6.44e-06	4.6e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—PTGS2—metabolic syndrome X	6.39e-06	4.57e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—APOE—metabolic syndrome X	6.31e-06	4.51e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—APOB—metabolic syndrome X	6.3e-06	4.5e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—NOS3—metabolic syndrome X	6.25e-06	4.47e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—APOA1—metabolic syndrome X	6.24e-06	4.46e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	6.19e-06	4.43e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PLA2G4A—metabolic syndrome X	6.12e-06	4.38e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—ABCA1—metabolic syndrome X	6.12e-06	4.37e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—SLC2A4—metabolic syndrome X	6.12e-06	4.37e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	6.11e-06	4.37e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PPARA—metabolic syndrome X	6.1e-06	4.36e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—GCK—metabolic syndrome X	6.07e-06	4.34e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—LIPC—metabolic syndrome X	6.07e-06	4.34e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PPARA—metabolic syndrome X	6.06e-06	4.33e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—APOC3—metabolic syndrome X	6.03e-06	4.31e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—LPL—metabolic syndrome X	6.01e-06	4.3e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—APOB—metabolic syndrome X	5.93e-06	4.24e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—GGT1—metabolic syndrome X	5.92e-06	4.24e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—GOT1—metabolic syndrome X	5.92e-06	4.24e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—TGFB1—metabolic syndrome X	5.91e-06	4.22e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—AGT—metabolic syndrome X	5.9e-06	4.22e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—AGT—metabolic syndrome X	5.87e-06	4.2e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CETP—metabolic syndrome X	5.86e-06	4.19e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PPARG—metabolic syndrome X	5.82e-06	4.16e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—IL6—metabolic syndrome X	5.81e-06	4.15e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—APOE—metabolic syndrome X	5.78e-06	4.14e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PLA2G4A—metabolic syndrome X	5.77e-06	4.13e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—APOE—metabolic syndrome X	5.75e-06	4.11e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—APOA1—metabolic syndrome X	5.72e-06	4.09e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—CD36—metabolic syndrome X	5.71e-06	4.08e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—INS—metabolic syndrome X	5.7e-06	4.08e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—APOA1—metabolic syndrome X	5.68e-06	4.07e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—LPL—metabolic syndrome X	5.66e-06	4.05e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—IL6—metabolic syndrome X	5.64e-06	4.03e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	5.61e-06	4.01e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PPARG—metabolic syndrome X	5.5e-06	3.93e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	5.44e-06	3.89e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—INS—metabolic syndrome X	5.39e-06	3.85e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—CD36—metabolic syndrome X	5.38e-06	3.85e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—AKT1—metabolic syndrome X	5.36e-06	3.83e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PPARA—metabolic syndrome X	5.31e-06	3.8e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	5.3e-06	3.79e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—GOT2—metabolic syndrome X	5.3e-06	3.79e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—IL6—metabolic syndrome X	5.27e-06	3.77e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—ALB—metabolic syndrome X	5.23e-06	3.74e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—AKT1—metabolic syndrome X	5.2e-06	3.72e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—AGT—metabolic syndrome X	5.14e-06	3.68e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—APOE—metabolic syndrome X	5.04e-06	3.6e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PPARG—metabolic syndrome X	5.04e-06	3.6e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—APOB—metabolic syndrome X	5.03e-06	3.59e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PPARG—metabolic syndrome X	5.01e-06	3.58e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PPARA—metabolic syndrome X	5e-06	3.58e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—NOS3—metabolic syndrome X	5e-06	3.58e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—APOA1—metabolic syndrome X	4.98e-06	3.56e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—INS—metabolic syndrome X	4.94e-06	3.53e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—ALB—metabolic syndrome X	4.94e-06	3.53e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—INS—metabolic syndrome X	4.91e-06	3.51e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PLA2G4A—metabolic syndrome X	4.89e-06	3.5e-05	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—AKT1—metabolic syndrome X	4.88e-06	3.49e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—AKT1—metabolic syndrome X	4.87e-06	3.48e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—AGT—metabolic syndrome X	4.85e-06	3.47e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—IL6—metabolic syndrome X	4.82e-06	3.45e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—LPL—metabolic syndrome X	4.8e-06	3.43e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—APOE—metabolic syndrome X	4.75e-06	3.4e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—NOS3—metabolic syndrome X	4.73e-06	3.38e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	4.72e-06	3.38e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	4.72e-06	3.38e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—APOA1—metabolic syndrome X	4.69e-06	3.36e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PTGS2—metabolic syndrome X	4.58e-06	3.27e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—GGT1—metabolic syndrome X	4.57e-06	3.27e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—GOT1—metabolic syndrome X	4.57e-06	3.27e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CD36—metabolic syndrome X	4.56e-06	3.26e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—ALB—metabolic syndrome X	4.53e-06	3.24e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—IL6—metabolic syndrome X	4.45e-06	3.18e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—AKT1—metabolic syndrome X	4.45e-06	3.18e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PPARG—metabolic syndrome X	4.39e-06	3.14e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—NOS3—metabolic syndrome X	4.33e-06	3.1e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PTGS2—metabolic syndrome X	4.32e-06	3.09e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—NOS3—metabolic syndrome X	4.31e-06	3.08e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—INS—metabolic syndrome X	4.3e-06	3.08e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PPARA—metabolic syndrome X	4.24e-06	3.03e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PPARG—metabolic syndrome X	4.14e-06	2.96e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—TGFB1—metabolic syndrome X	4.14e-06	2.96e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—AGT—metabolic syndrome X	4.11e-06	2.94e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—AKT1—metabolic syndrome X	4.11e-06	2.94e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—INS—metabolic syndrome X	4.06e-06	2.9e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—APOE—metabolic syndrome X	4.02e-06	2.88e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—APOA1—metabolic syndrome X	3.98e-06	2.84e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PTGS2—metabolic syndrome X	3.96e-06	2.83e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—ALB—metabolic syndrome X	3.95e-06	2.82e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PTGS2—metabolic syndrome X	3.94e-06	2.82e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—APOB—metabolic syndrome X	3.88e-06	2.77e-05	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—AKT1—metabolic syndrome X	3.78e-06	2.71e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—NOS3—metabolic syndrome X	3.77e-06	2.7e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	3.77e-06	2.7e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—ALB—metabolic syndrome X	3.72e-06	2.66e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—LPL—metabolic syndrome X	3.7e-06	2.65e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—NOS3—metabolic syndrome X	3.56e-06	2.54e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—AKT1—metabolic syndrome X	3.53e-06	2.52e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CD36—metabolic syndrome X	3.52e-06	2.52e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PPARG—metabolic syndrome X	3.5e-06	2.51e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PTGS2—metabolic syndrome X	3.45e-06	2.47e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—INS—metabolic syndrome X	3.44e-06	2.46e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PPARA—metabolic syndrome X	3.27e-06	2.34e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PTGS2—metabolic syndrome X	3.25e-06	2.33e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—AKT1—metabolic syndrome X	3.21e-06	2.3e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—AGT—metabolic syndrome X	3.17e-06	2.27e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—ALB—metabolic syndrome X	3.15e-06	2.25e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—IL6—metabolic syndrome X	3.12e-06	2.23e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—APOE—metabolic syndrome X	3.1e-06	2.22e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—APOA1—metabolic syndrome X	3.07e-06	2.19e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—NOS3—metabolic syndrome X	3.01e-06	2.16e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—AKT1—metabolic syndrome X	2.87e-06	2.06e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PTGS2—metabolic syndrome X	2.76e-06	1.97e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PPARG—metabolic syndrome X	2.7e-06	1.93e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—INS—metabolic syndrome X	2.65e-06	1.9e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ALB—metabolic syndrome X	2.43e-06	1.74e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—NOS3—metabolic syndrome X	2.33e-06	1.66e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—AKT1—metabolic syndrome X	2.3e-06	1.64e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—AKT1—metabolic syndrome X	2.17e-06	1.55e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	2.13e-06	1.52e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—AKT1—metabolic syndrome X	1.99e-06	1.42e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—AKT1—metabolic syndrome X	1.98e-06	1.42e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—AKT1—metabolic syndrome X	1.74e-06	1.24e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—AKT1—metabolic syndrome X	1.64e-06	1.17e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—AKT1—metabolic syndrome X	1.39e-06	9.91e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—AKT1—metabolic syndrome X	1.07e-06	7.65e-06	CbGpPWpGaD
